Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Meridian Bioscience Preliminary Q2 Revenues Up 14 Percent

Meridian Bioscience Preliminary Q2 Revenues Up 14 Percent

Apr 02, 2020
|
staff reporter

NEW YORK – Meridian Bioscience announced on Thursday that its preliminary fiscal Q2 revenues are expected to grow about 14 percent year over year.

For the quarter, the company anticipates revenues of about $57 million, up from $50.2 million in the year-ago quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Same Old Error

The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.

Own Merits

NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.

Back to Neanderthals

Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.

PNAS Papers on Small Molecule From Soil Bacteria, Circulating Tumor Cell Chip, More

In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.

What's Popular?

In Business News

  1. Progenity Asks Court to Declare Non-Infringement of Natera Patents

  2. Cancer AI Startup Nucleai Raises $6.5M in Series A Financing

  3. Quidel Preliminary Q2 Revenues Jump More Than 86 Percent

  4. Surge in Stocks of SARS-CoV-2 Dx Developers Pushes GenomeWeb Index Up 15 Percent in H1 2020

  5. DiaSorin Molecular Gets CE Mark for Flu, RSV Assay

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.